Method for the treatment of inflammation

Details Method for the treatment of inflammation Method for the treatment of inflammation

2005-05-10

2005-05-10

Nguyen, Dave T. (Department: 1635)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

C424S093100, C435S243000, C435S253100

Reexamination Certificate

active

06890911

ABSTRACT:
The present invention relates to a mycobacterial deoxyribonucleic acid (B-DNA) preserved and complexed on the mycobacterial cell wall (BCC) and a pharmaceutically acceptable carrier, wherein the BCC is effective in treating an inflammation in an animal having an inflammation. More particularly, the present invention relates to aMycobacterium phleideoxyribonucleic acid (M-DNA) preserved and complexed onMycobacterium phleicell wall (MCC) and a pharmaceutically acceptable carrier, wherein the MCC is effective in treating an inflammation in an animal having an inflammation.

REFERENCES:
patent: 5759554 (1998-06-01), Alkemade et al.
patent: 6326357 (2001-12-01), Phillips et al.
patent: WO 99 07383 (1999-02-01), None
Heller A. et al. Lipid mediators in inflammatory disorders. Drugs 1998; vol. 55, No. 4, pp. 487-496.*
E Beltan et al., Microbial Pathogenesis, “Secretion of cytokines by human macrophages upon infection by pathogenic and non-pathogenic mycogbacteria,” 2000, 28:313-318.*
Bermudez et al.,Infection and Immunity,“Infection withMycobacterium aviumInduces Production of Interleukin-10(IL-10),and Administration of Anti-IL-10 Antibody is Associated with Enhanced Resistance to Infection in Mice,”Jul. 1993,vol. 61, No. 7, p3093-3097.*
CAN Moura et al., Immunology, “Lipids fromMycobacterium lepraecell wall suppress T-cell activation in vivo and in vitro,” 1997, 92, pp. 429-436.*
ACN Moura et al.,Immunology,“Lipids fromMycobacterium lipraecell wall suppress T-cell activation in vivo and in vitro,” 1997, 92, pp. 429-436.*
MC Filion et al.,Mycobacterium phleicell wall complex, a new anti-tumoral agent, induces IL-12 synthesis by monocyte/macrophages via associated DNA, Nov. 1997, Abstract.*
MC Filion et al., J.Pharm. Pharmacol, “Mycobacterial cell wall-DNA complex induces apoptosis in cancer cells,” 1998, 50, pp. 39.*
LE Bermudez et at., Infection and Immunity, “Infection withMycobacteruim aviumInduces Production of Interleukin-10 . . . Antibody is Associated with Enhanced Resistance to Infection in Mice,”Jul. 1993, pp. 3093-3097.*
Database Biosis Online, Biosciences Information Service, Philadelphia, PA, US Filion, M.C., et al., “Mycobacterial cell wall-DNA complex induces apoptosis in cancer cells”, (Sep. 1998), XP002133100, Journ. of Pharmacy and Pharmacology, 135thMeeting of the British Pharmaceutical Conference Eastbourne, England, UK Sep. 8-11, 1998, vol. 50, p. 39.
Database Biosis Online, Biosciences Information Service, Philadelphia, PA, US Filion, M.C., et al., “Mycobacterium phleicell wall complex, a new anti-tumoral agent, induces IL-12 synthesis by monocyte/macrophages via associated DNA”, (Nov. 15, 1997), XP002133101, Suppl. 1 Part 2, Thirty-Ninth Annual Meeting of the American Society of Hematology San Diego, California, USA Dec. 5-9, 1997, The American Society of Hematology, vol. 90, p. 58B.

Affiliated with

Also associated with

Rating

Method for the treatment of inflammation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for the treatment of inflammation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for the treatment of inflammation will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3429113